Covered recipient · General Payments record
ALYSSA DOYLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,314.61
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,142.36 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $469.04 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $165.65 | 3 |
| PAINTEQ LLC | $155.93 | 2 |
| Novo Nordisk AS | $123.50 | 1 |
| PFIZER INC. | $33.90 | 2 |
| FORTE BIO-PHARMA LLC | $30.65 | 1 |
| Octapharma USA, Inc. | $28.53 | 1 |
| Averitas Pharma Inc. | $27.85 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.34 | 1 |
| Neurelis, Inc. | $22.84 | 1 |
| ABBVIE INC. | $22.19 | 1 |
| Alnylam Pharmaceuticals Inc. | $21.79 | 1 |
| Janssen Pharmaceuticals, Inc | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.19 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107040206 | CMS |
| Alnylam Pharmaceuticals Inc. | $21.79 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125834649 | CMS |
| Averitas Pharma Inc. | $27.85 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133456986 | CMS |
| Boston Scientific Corporation | $16.33 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092528199 | CMS |
| Boston Scientific Corporation | $4.57 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092528197 | CMS |
| Boston Scientific Corporation | $144.75 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092528201 | CMS |
| Forte Bio-Pharma LLC | $30.65 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142422727 | CMS |
| Janssen Pharmaceuticals, Inc | $15.15 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078050606 | CMS |
| Neurelis, Inc. | $22.84 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145662904 | CMS |
| Nevro Corp. | $148.22 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775485 | CMS |
| Nevro Corp. | $143.35 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775437 | CMS |
| Nevro Corp. | $40.92 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775457 | CMS |
| Nevro Corp. | $52.25 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775439 | CMS |
| Nevro Corp. | $84.30 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775459 | CMS |
| Novo Nordisk Inc | $123.50 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100460918 | CMS |
| Octapharma USA, Inc. | $28.53 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142321756 | CMS |
| PAINTEQ LLC | $132.79 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142006802 | CMS |
| PAINTEQ LLC | $23.14 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142006806 | CMS |
| PFIZER INC. | $18.11 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131150480 | CMS |
| PFIZER INC. | $15.79 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131252471 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.34 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137736414 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.